BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1920429)

  • 1. Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants.
    Tulip WR; Varghese JN; Baker AT; van Donkelaar A; Laver WG; Webster RG; Colman PM
    J Mol Biol; 1991 Sep; 221(2):487-97. PubMed ID: 1920429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.
    Bossart-Whitaker P; Carson M; Babu YS; Smith CD; Laver WG; Air GM
    J Mol Biol; 1993 Aug; 232(4):1069-83. PubMed ID: 8371267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.
    Baker AT; Varghese JN; Laver WG; Air GM; Colman PM
    Proteins; 1987; 2(2):111-7. PubMed ID: 3447170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic structure and variation in an influenza virus N9 neuraminidase.
    Webster RG; Air GM; Metzger DW; Colman PM; Varghese JN; Baker AT; Laver WG
    J Virol; 1987 Sep; 61(9):2910-6. PubMed ID: 3612957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.
    Tulip WR; Varghese JN; Laver WG; Webster RG; Colman PM
    J Mol Biol; 1992 Sep; 227(1):122-48. PubMed ID: 1381757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution.
    Varghese JN; Colman PM
    J Mol Biol; 1991 Sep; 221(2):473-86. PubMed ID: 1920428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases.
    Varghese JN; Colman PM; van Donkelaar A; Blick TJ; Sahasrabudhe A; McKimm-Breschkin JL
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11808-12. PubMed ID: 9342319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).
    Gulati U; Hwang CC; Venkatramani L; Gulati S; Stray SJ; Lee JT; Laver WG; Bochkarev A; Zlotnick A; Air GM
    J Virol; 2002 Dec; 76(23):12274-80. PubMed ID: 12414967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.
    Varghese JN; Epa VC; Colman PM
    Protein Sci; 1995 Jun; 4(6):1081-7. PubMed ID: 7549872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase.
    Air GM; Laver WG; Webster RG
    J Virol; 1990 Dec; 64(12):5797-803. PubMed ID: 1700825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6.
    Venkatramani L; Johnson ES; Kolavi G; Air GM; Brouillette WJ; Mooers BH
    BMC Struct Biol; 2012 May; 12():7. PubMed ID: 22559154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes.
    Wang T; Wade RC
    J Med Chem; 2001 Mar; 44(6):961-71. PubMed ID: 11300878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.
    Wei DQ; Du QS; Sun H; Chou KC
    Biochem Biophys Res Commun; 2006 Jun; 344(3):1048-55. PubMed ID: 16647045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase.
    Nuss JM; Whitaker PB; Air GM
    Proteins; 1993 Feb; 15(2):121-32. PubMed ID: 7680132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.
    Burmeister WP; Ruigrok RW; Cusack S
    EMBO J; 1992 Jan; 11(1):49-56. PubMed ID: 1740114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of two mutant neuraminidase-antibody complexes with amino acid substitutions in the interface.
    Tulip WR; Varghese JN; Webster RG; Laver WG; Colman PM
    J Mol Biol; 1992 Sep; 227(1):149-59. PubMed ID: 1522584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus neuraminidase with hemagglutinin activity.
    Laver WG; Colman PM; Webster RG; Hinshaw VS; Air GM
    Virology; 1984 Sep; 137(2):314-23. PubMed ID: 6485252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the requirements for an antibody epitope on influenza virus neuraminidase: how tolerant are protein epitopes?
    Nuss JM; Air GM
    J Mol Biol; 1994 Jan; 235(2):747-59. PubMed ID: 7507170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor.
    Varghese JN; McKimm-Breschkin JL; Caldwell JB; Kortt AA; Colman PM
    Proteins; 1992 Nov; 14(3):327-32. PubMed ID: 1438172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies.
    White CL; Janakiraman MN; Laver WG; Philippon C; Vasella A; Air GM; Luo M
    J Mol Biol; 1995 Feb; 245(5):623-34. PubMed ID: 7844831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.